Login

President Satoshi Ogiso: Leading the Way Forward | Satoshi Ogiso - President & CEO of Hino Motors 00:10:00

Share On Facebook Share On Twitter

Satoshi Ogiso is President/CEO/Chro at Hino Motors Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Oak Financial Group Client Update | Rick Moore - Financial Advisor/Owner/Managing Partner of The Oak Financial Group, LLC
00:00:00
US companies set the benchmark for Motif Bio - Graham Lumsden, chief executive of Motif Bio PLC
00:10:00
CEO of Specialty Metals: We are no longer asked by customers to match Chinese prices | Gervais Jacques, CEO, 5N Plus Inc
00:10:00
committed and has built a community of over 5,000 incredible, driven, ambitious builders|Matthew Colford,Investment Partner,Human Capital
00:10:00
Bolara Rocks Targets Large Copper Deposits in Argentina’s High Andes
00:10:00
PIMCO CIO Dan Iverson's Take on the Current Market Environment and Bond Investing | Dan Iverson, CIO, PIMCO.
00:10:00
Embracing personal experiences and a vision for sustainability | Pieter Loose, CEO, Ekopak NV.
00:10:00
Science Outreach category from Nature in partnership|Ananya Vasagiri, Analyst,Schematic Ventures
00:10:00
Importance of Dependency in Tax Credits and Due Diligence
00:10:00
Climate change refers to long-term shifts in temperatures and weather patterns|David Danielson,Managing Director,Breakthrough Energy Ventures
00:10:00
Market Trends This Fall: Understanding the Slide | Morgan Christen, CEO, Spinnaker Investment Group, LLC.
00:10:00
Bridging Global Relations: Insights from Kirill Dmitriev | Kirill Dmitriev - CEO, Russian Direct Investment Fund

© 2026 Nehu